A message from Dr. Kunkel:
Earlier today, Rebecca Cunningham, U-M Vice President for Research, announced that a subset of Tier 2 human research studies (Tier 2 that are observational) will be required to pause by Friday, November 20. Please CLICK HERE for more details about the requirements of this pause, as well as definitions of the clinical research tiers.
This pause, as well as Governor Whitmer’s announcement last night, does not affect the 60% capacity for bench laboratory research, human subjects research classified as Tier 0 or Tier 1, or our ability to continue to host undergraduate students in the labs (at the PI’s discretion). However, as we have seen in the headlines and via our own Michigan Medicine town halls, community spread of COVID-19 is of enormous concern across the state. As we progress into the holiday season, we must all remain vigilant to protect our work, our colleagues, and our families and communities.
Please continue to monitor the UMOR Research Re-engagement and UMMS Research Operations websites for the latest information, and thank you for your flexibility and commitment to our research mission here at the University of Michigan.
Steven L. Kunkel, Ph.D.
Executive Vice Dean for Research, Medical School
Chief Scientific Officer, Michigan Medicine
Peter A. Ward Distinguished University Professor
Endowed Professor of Pathology Research